Dongqi Shen

Statistics

Publications

Citations

190

H-Index

Active since

2019

Affiliations

First Affiliated Hospital of Zhengzhou University(Current)

Dongqi Shen is an author at First Affiliated Hospital of Zhengzhou University specializing in oncology, medicine, and hepatocellular carcinoma treatment.

Publications per year

2019–2021

Publications

Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb trial (TRAVERSE)

Markus Moehler, Jeong Heo, H.C. Lee et al. · OncoImmunology · 2019 · 130 citations · Full text

Medicine, Immunology, Oncology +17

Overexpressed DEPDC1B contributes to the progression of hepatocellular carcinoma by CDK1

Xiaowei Dang, Qi Pan, Hao‐Hao Wang et al. · Aging · 2021 · 27 citations · Full text

Medicine, Molecular Biology, Oncology +14

Clinical characteristics and outcome of primary hepatic neuroendocrine tumors after comprehensive therapy

Hao‐Hao Wang, Zhao-Chen Liu, Gong Zhang et al. · World Journal of Gastrointestinal Oncology · 2020 · 19 citations · Full text

Medicine, Oncology, Pathology +17

Assessing health-related quality of life and health utilities in patients with chronic hepatitis B-related diseases in China: a cross-sectional study

Meng Zhang, Yaoguang Li, Zihao Fan et al. · BMJ Open · 2021 · 14 citations · Full text

Pharmacy, Pharmacoeconomics, Cost-effectiveness Analysis +16

1–4 of 4